نتایج جستجو برای: fcγriiia

تعداد نتایج: 216  

Journal: :Cancer immunology research 2015
Scot D Liu Cecile Chalouni Judy C Young Teemu T Junttila Mark X Sliwkowski John B Lowe

Antibody-dependent cellular cytotoxicity (ADCC) is a key mechanism by which therapeutic antibodies mediate their antitumor effects. The absence of fucose on the heavy chain of the antibody increases the affinity between the antibody and FcγRIIIa, which results in increased in vitro and in vivo ADCC compared with the fucosylated form. However, the cellular and molecular mechanisms responsible fo...

Journal: :Blood 2014
Rick Kapur Iwan Kustiawan Anne Vestrheim Carolien A M Koeleman Remco Visser Helga K Einarsdottir Leendert Porcelijn Dave Jackson Belinda Kumpel André M Deelder Dennis Blank Björn Skogen Mette Kjaer Killie Terje E Michaelsen Masja de Haas Theo Rispens C Ellen van der Schoot Manfred Wuhrer Gestur Vidarsson

Immunoglobulin G (IgG) formed during pregnancy against human platelet antigens (HPAs) of the fetus mediates fetal or neonatal alloimmune thrombocytopenia (FNAIT). Because antibody titer or isotype does not strictly correlate with disease severity, we investigated by mass spectrometry variations in the glycosylation at Asn297 in the IgG Fc because the composition of this glycan can be highly var...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2013
Raghvendra M Srivastava Steve C Lee Pedro A Andrade Filho Christopher A Lord Hyun-Bae Jie H Carter Davidson Andrés López-Albaitero Sandra P Gibson William E Gooding Soldano Ferrone Robert L Ferris

PURPOSE Tumor antigen-specific monoclonal antibodies (mAb) block oncogenic signaling and induce Fcγ receptor (FcγR)-mediated cytotoxicity. However, the role of CD8(+) CTL and FcγR in initiating innate and adaptive immune responses in mAb-treated human patients with cancer is still emerging. EXPERIMENTAL DESIGN FcγRIIIa codon 158 polymorphism was correlated with survival in 107 cetuximab-treat...

2016
SAMO ROŽMAN SRDJAN NOVAKOVIĆ IZTOK GRABNAR PETRA CERKOVNIK BARBARA JEZERŠEK NOVAKOVIĆ

Rituximab is a monoclonal antibody routinely used in the treatment of B-cell non-Hodgkin lymphomas. It mediates antibody-dependent cellular cytotoxicity of B lymphocytes by bridging them with Fcγ receptors (FcγR) on effector cells. Several polymorphisms in the FcγR genes have been identified to influence rituximab binding to FcγR, thus altering its antitumor effect in indolent lymphomas. In the...

2016
Anil K. Chauhan

Both lymphoid and myeloid cells express Fc receptors (FcRs). Low-affinity FcRs engage circulating immune complexes, which results in the cellular activation and pro-inflammatory cytokine production. FcRs participate in the internalization, transport, and/or recycling of antibodies and antigens. Cytosolic FcRs also route these proteins to proteasomes and antigen-presentation pathways. Non-activa...

Journal: :International immunology 2012
Yuji Mishima Yasuhito Terui Yuko Mishima Ryoko Kuniyoshi Satoshi Matsusaka Mariko Mikuniya Kiyotsugu Kojima Kiyohiko Hatake

The anti-CD20 chimeric monoclonal antibody rituximab mediates cytotoxicity in malignant B cells via multiple mechanisms, including complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC) and direct induction of apoptosis. To optimize treatment of non-Hodgkin's lymphoma, a fuller understanding of these mechanisms and their relative contributions to clinical effic...

2002
A Milicic R Misra S Agrawal A Aggarwal M A Brown B P Wordsworth

Objectives: To investigate the association of the FcγRIIIA gene with rheumatoid arthritis (RA) in two genetically distinct groups: a white group from the United Kingdom and a northern Indian group. Methods: The distributions of the two alleles of the FcγRIIIA F158V polymorphism were determined in 398 white patients from the United Kingdom and 63 Indian patients with RA and compared with those f...

2017
Karin P M Geuijen Cindy Oppers-Tiemissen David F Egging Peter J Simons Louis Boon Richard B M Schasfoort Michel H M Eppink

The interactions of therapeutic antibodies with fragment crystallizable γ (Fcγ) receptors and neonatal Fc receptors (FcRn) are measured in vitro as indicators of antibody functional performance. Antibodies are anchored to immune cells through the Fc tail, and these interactions are important for the efficacy and safety of therapeutic antibodies. High-throughput binding studies on each of the hu...

Journal: :iranian journal of immunology 0
alireza nikseresht department of neurology mohammad ali azizi department of neurology behrouz gharesi-fard department of immunology eskandar kamali sarvestani autoimmune diseases research centre, shiraz medical school, shiraz university of medical sciences, shiraz, iran

background: multiple sclerosis (ms), the most common demyelinating disease of the cns, is immunologically mediated in genetically susceptible individuals. receptors for the fc fragment of igg (fcγr) might induce inflammatory responses through linking the humoral and cellular immune responses by targeting immune complexes to effector cells. polymorphisms in some fcγr genes are associated with va...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید